TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Rekomedica AB
Closing information (x1000 EUR)
Closing information | 2023/08 | 2022/08 | 2021/08 |
Turnover |
196
|
155
|
83 |
Financial expenses |
2
|
3
|
4 |
Earnings before taxes |
3
|
32
|
22 |
EBITDA |
7
|
37
|
29 |
Total assets |
36
|
40
|
30 |
Current assets |
31
|
37
|
25 |
Current liabilities |
3
|
13
|
5 |
Equity capital |
-13
|
-16
|
-42 |
- share capital |
8
|
9
|
10 |
Employees (average) |
2
![]() |
2
|
1 |
Financial ratios
Fiscal year | 2023/08 | 2022/08 | 2021/08 |
Solvency |
-36.1%
|
-40.0%
|
-140.0% |
Turnover per employee |
98
|
78
|
83 |
Profit as a percentage of turnover |
1.5%
|
20.6%
|
26.5% |
Return on assets (ROA) |
13.9%
|
87.5%
|
86.7% |
Current ratio |
1033.3%
|
284.6%
|
500% |
Return on equity (ROE) |
-23.1%
|
-200%
|
-52.4% |
Change turnover |
57
|
76
|
21 |
Change turnover % |
41%
|
96%
|
34% |
Chg. No. of employees |
0
|
1
|
0 |
Chg. No. of employees % |
0%
|
100%
|
0% |
Total value of public sale
Fiscal year | 2023/08 | 2022/08 | 2021/08 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.